Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-14-002129
Filing Date
2014-01-10
Accepted
2014-01-10 16:40:49
Documents
2
Period of Report
2014-01-08

Document Format Files

Seq Description Document Type Size
1 JAN 2014 GRANTS rrd399591.html 4  
1 JAN 2014 GRANTS rrd399591.xml 4 6543
2 POWER OF ATTORNEY rrd359564_407456.htm EX-24. 3553
  Complete submission text file 0001181431-14-002129.txt   11729
Mailing Address FIRST FLOOR, BLOCK 3, THE OVAL, SHELBOURNE ROAD, BALLSBRIDGE DUBLIN L2 00000
Business Address FIRST FLOOR, BLOCK 3, THE OVAL, SHELBOURNE ROAD, BALLSBRIDGE DUBLIN L2 00000 353 1 6699 020
AMARIN CORP PLC\UK (Issuer) CIK: 0000897448 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2483 EAST BAYSHORE ROAD SUITE 100 PALO ALTO CA 94303
Business Address
Ketchum Steven B (Reporting) CIK: 0001289884 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-21392 | Film No.: 14522278